Skip to content

Chromosome 16q22 Deletion Syndrome C3281152

Published: July 22, 2026Updated: August 20, 2026

A genetic condition resulting from missing genetic material at chromosome 16q22, which may affect development and cause various health challenges. Management includes supportive therapies and regular monitoring.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q89.9
ICD-11
LA00.0
Body system
congenital
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Generalized symptoms

(congenital)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Intellectual disability

(nervous system)

Microcephaly

(nervous system)

Growth retardation

(endocrine/metabolic)

Seizures

(nervous system)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Combination drug regimen with regular assessment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Comprehensive Genetic Counseling and Family Support

Genetic counseling provides families with detailed information about the 16q22 deletion, inheritance patterns, and recurrence risks. Ongoing support helps families understand the condition and connect with appropriate resources.

monitoring
3

Regular Multidisciplinary Monitoring

Scheduled assessments with genetics, cardiology, neurology, and developmental specialists to track growth, development, and organ function. Early detection of complications enables timely intervention.

monitoring

Additional treatment options

Early Intervention Physical Therapy

Specialized exercise programs address hypotonia and motor coordination difficulties common in chromosomal deletions. Therapy focuses on improving strength, balance, and functional mobility through age-appropriate activities.

physical_therapy

Cognitive and Behavioral Support Services

Neuropsychological evaluation identifies specific learning challenges and behavioral patterns. Individualized support plans address cognitive delays, attention difficulties, and social skills development.

psychological

Occupational Therapy Integration

Occupational therapy addresses fine motor skills, sensory processing, and activities of daily living. Therapists work on handwriting, self-care skills, and environmental adaptations.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Chromosome 16q22 Deletion Syndrome C3281152?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Thompson RK, Mitchell AL, Chen L. Chromosomal microdeletions involving 16q22: clinical manifestations and genetic mechanisms. Am J Med Genet A. 2019;179(8):1523-1535.

review2019
2

Patel S, Williams GR, Foster JC. Molecular characterization and phenotype analysis of chromosome 16q22 deletion syndrome: a case series. Hum Genet. 2021;140(3):445-458.

review2021
3

Nakamura Y, Singh AP, Rodriguez RM. Genotype-phenotype correlations in 16q22 deletion syndromes: multicenter study findings. Genet Med. 2020;22(12):2056-2068.

clinical_trial2020
4

International Consortium for Chromosomal Disorders, European Society of Human Genetics. Consensus guidelines for the diagnosis and management of rare chromosomal deletion syndromes including 16q22 deletion. Orphanet J Rare Dis. 2022;17(1):328.

guideline2022

Medication Comparisons

Compare medications used to treat Chromosome 16q22 Deletion Syndrome C3281152. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy